Two executives of a telehealth company were indicted for distributing Adderall and stimulants for ADHD to patients who didn't need them, causing possible disruptions in care for 50,000 patients nationwide.
The scheme exploited the pandemic to defraud taxpayers, causing frustration for those with ADHD who struggle to get consistent care due to fraudulent activities.
[
Collection
]
[
|
...
]